Related Experiment Video
Updated: May 5, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints
L H Vandenberghe1, E Breous, H-J Nam
1Gene Therapy Program, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Novel adeno-associated virus (AAV) vectors were engineered by analyzing capsid structure. Modifications to specific amino acids improved vector manufacturing and gene transfer efficiency for diverse therapeutic applications.
Area of Science:
- * Molecular biology
- * Virology
- * Gene therapy
Background:
- * Adeno-associated virus (AAV) vectors are key for in vivo gene transfer.
- * The AAV capsid mediates cellular interactions and influences vector properties.
- * Specific capsid amino acids are critical determinants of AAV vector function.
Purpose of the Study:
- * To develop novel AAV vectors by analyzing capsid structure-function relationships.
- * To identify and modify specific capsid residues impacting vector manufacturing and transduction.
- * To create a diverse portfolio of AAV vectors for enhanced gene therapy applications.
Main Methods:
- * Structure-function analysis of naturally occurring AAV capsid isolates.
- * Identification of 'singleton' residues (variable amino acids in conserved positions).
- * Site-directed mutagenesis to alter singleton residues to conserved amino acids.
Main Results:
- * Singleton residues significantly impact AAV vector manufacturability and transduction.
- * Residues at monomer-monomer interfaces are implicated in particle assembly.
- * Modifying singletons rescued defective AAV isolates, creating a portfolio of six clades and three niches.
- * In vivo studies revealed clade-specific tropism for intravenous and intramuscular delivery.
Conclusions:
- * Understanding AAV capsid structure-function relationships enables rational vector design.
- * Targeted modification of capsid singletons enhances AAV vector performance.
- * The developed AAV vector portfolio offers diverse options for gene therapy applications.
More Related Videos
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
09:12Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
Published on: April 5, 2024
Related Concept Videos
Viral Structure
Size and Structure of Viral Genomes